CAMLINFINE

Camlin Fine Sciences Limited

Specialty chemicals and flavours business with vanillin franchise

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

camlinfs.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹95.09
Market cap
1,827 Cr
Stock P/E
310.6
P/B
1.83
Dividend yield
0.3%
ROE (FY26)
2.8%
ROCE (FY26)
5.8%
Operating margin (FY26)
2.1%
Debt / equity (FY26)
0.67
OCF / EBITDA (FY26)
76.8%
OCF / EBITDA (3Y)
63.7%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

CFS (Camlin Fine Sciences) makes specialty chemicals, mainly blends, shelf-life ingredients, aroma chemicals such as vanillin, and performance chemicals, and sells them to customers across the world, including multinational fragrance and flavour companies.

Company snapshot

38thBy market cap

Ranked among 68 companies in Specialty Chemicals.

What we see

Concerns
  • ✗Net margin is very thin at 1.4% — little room for error if costs rise.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales406 Cr386 Cr402 Cr396 Cr423 Cr433 Cr437 Cr424 Cr460 Cr457 Cr425 Cr520 Cr
Operating expenses (approx.)381 Cr363 Cr415 Cr378 Cr380 Cr385 Cr378 Cr405 Cr426 Cr435 Cr404 Cr511 Cr
EBITDA25 Cr23 Cr-13 Cr18 Cr43 Cr49 Cr59 Cr19 Cr33 Cr22 Cr21 Cr9 Cr
OPM %6.2%6.0%-3.3%4.6%10.2%11.3%13.6%4.5%7.3%4.8%5.0%1.8%
Other income2 Cr2 Cr6 Cr2 Cr12 Cr1 Cr10 Cr9 Cr5 Cr3 Cr24 Cr1 Cr
Interest20 Cr14 Cr16 Cr23 Cr26 Cr34 Cr16 Cr16 Cr19 Cr18 Cr23 Cr14 Cr
Depreciation19 Cr21 Cr20 Cr20 Cr21 Cr14 Cr18 Cr17 Cr19 Cr17 Cr21 Cr19 Cr
Profit before tax-12 Cr-10 Cr-94 Cr-23 Cr-142 Cr-0.33 Cr8 Cr-11 Cr-9 Cr-37 Cr80 Cr-34 Cr
Tax %-72.4%-46.7%12.5%-47.6%18.4%-2182.8%98.6%0.1%-65.4%-0.1%-7.6%1.4%
Net profit-21 Cr-14 Cr-82 Cr-35 Cr-116 Cr-7 Cr0.11 Cr-11 Cr-15 Cr-37 Cr86 Cr-34 Cr
EPS (₹)₹-1.17₹-0.71₹-4.64₹-2.03₹-5.98₹-0.24₹-0.04₹-0.53₹-0.76₹-1.91₹4.59₹-1.65

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales547 Cr723 Cr892 Cr1,049 Cr1,187 Cr1,412 Cr1,682 Cr1,613 Cr1,667 Cr1,723 CrSign in free for the trailing twelve months
Operating expenses (approx.)519 Cr710 Cr824 Cr918 Cr1,005 Cr1,259 Cr1,476 Cr1,539 Cr1,458 Cr1,616 CrSign in free for the trailing twelve months
EBITDA28 Cr13 Cr69 Cr131 Cr182 Cr153 Cr205 Cr74 Cr208 Cr107 CrSign in free for the trailing twelve months
OPM %5.2%1.7%7.7%12.5%15.3%10.8%12.2%4.6%12.5%6.2%Sign in free for the trailing twelve months
Other income15 Cr12 Cr14 Cr3 Cr5 Cr33 Cr6 Cr16 Cr14 Cr29 CrSign in free for the trailing twelve months
Interest27 Cr28 Cr37 Cr43 Cr38 Cr36 Cr59 Cr60 Cr100 Cr73 CrSign in free for the trailing twelve months
Depreciation22 Cr27 Cr29 Cr33 Cr44 Cr56 Cr63 Cr79 Cr64 Cr71 CrSign in free for the trailing twelve months
Profit before tax-6 Cr-31 Cr17 Cr58 Cr105 Cr94 Cr80 Cr-99 Cr-158 Cr23 CrSign in free for the trailing twelve months
Tax %26.2%22.0%82.0%48.7%37.8%35.8%50.5%-5.7%-0.0%-1.2%Sign in free for the trailing twelve months
Net profit-4 Cr-24 Cr3 Cr30 Cr65 Cr60 Cr40 Cr-105 Cr-158 Cr24 CrSign in free for the trailing twelve months
EPS (₹)₹-1.26₹-0.38₹0.05₹2.50₹4.13₹4.65₹3.45₹-5.58₹-8.03₹1.46Sign in free for the trailing twelve months
Dividend payout %————8.3%0.0%0.0%——0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital10 Cr12 Cr12 Cr12 Cr13 Cr16 Cr16 Cr17 Cr19 Cr19 Cr
Reserves202 Cr359 Cr359 Cr391 Cr631 Cr732 Cr804 Cr848 Cr883 Cr1,022 Cr
Borrowings321 Cr357 Cr432 Cr490 Cr490 Cr623 Cr780 Cr658 Cr646 Cr668 Cr
Other liabilities121 Cr226 Cr225 Cr284 Cr278 Cr412 Cr456 Cr437 Cr503 Cr655 Cr
Total liabilities673 Cr1,016 Cr1,087 Cr1,234 Cr1,482 Cr1,800 Cr2,060 Cr1,952 Cr2,024 Cr2,324 Cr
Fixed assets (net)152 Cr207 Cr209 Cr203 Cr482 Cr482 Cr794 Cr757 Cr593 Cr625 Cr
CWIP8 Cr13 Cr54 Cr176 Cr24 Cr215 Cr41 Cr46 Cr10 Cr33 Cr
Investments19 Cr115 Cr13 Cr9 Cr9 Cr7 Cr8 Cr8 Cr63 Cr30 Cr
Loans & advances——3 Cr1 Cr0.87 Cr0.08 Cr10 Cr10 Cr10 Cr0 Cr
Inventories198 Cr239 Cr285 Cr298 Cr320 Cr371 Cr568 Cr513 Cr527 Cr504 Cr
Trade receivables145 Cr205 Cr209 Cr253 Cr271 Cr300 Cr305 Cr285 Cr328 Cr373 Cr
Cash & bank21 Cr38 Cr53 Cr52 Cr76 Cr108 Cr94 Cr80 Cr104 Cr109 Cr
Other assets131 Cr199 Cr261 Cr241 Cr300 Cr318 Cr241 Cr253 Cr389 Cr650 Cr
Total assets673 Cr1,016 Cr1,087 Cr1,234 Cr1,482 Cr1,800 Cr2,060 Cr1,952 Cr2,024 Cr2,324 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity-9 Cr-15 Cr-9 Cr86 Cr117 Cr145 Cr51 Cr139 Cr27 Cr82 Cr
Cash from investing-83 Cr-149 Cr-2 Cr-90 Cr-133 Cr-249 Cr-125 Cr-66 Cr-75 Cr-53 Cr
Cash from financing91 Cr182 Cr26 Cr3 Cr39 Cr136 Cr60 Cr-86 Cr72 Cr-25 Cr
Net cash flow-0.92 Cr18 Cr15 Cr-0.85 Cr23 Cr32 Cr-14 Cr-13 Cr24 Cr4 Cr
Free cash flow (OCF − Capex)-39 Cr-35 Cr-78 Cr-48 Cr34 Cr-68 Cr-93 Cr78 Cr-16 Cr25 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %3.8%-0.3%6.2%10.7%11.9%9.3%8.7%-2.6%-3.8%5.8%
ROE %-4.9%-6.8%0.1%6.6%7.1%7.9%6.3%-10.8%-15.9%2.8%
Debtor days961038588837766657279
Inventory days246226221218239186242251244223
Days payable97168132127118117123159175223
Cash conversion cycle24516117417920414618515614178
OCF / EBITDA %-30.9%n.m.-13.1%65.8%64.5%95.2%24.8%188.0%12.8%76.8%
OCF / EBITDA % (3 years)——-30.3%29.1%51.0%74.9%58.1%77.6%44.4%63.7%
Debt / equity1.510.961.161.210.760.830.950.770.740.67
Current ratio1.091.411.441.231.661.501.371.361.401.27
Net debt / EBITDA10.67—5.513.352.283.373.347.812.605.24